Trial Profile
Short-term Efficacy of Antidepressant in Patients Underwent TKA
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Depressive disorders; Pain
- Focus Therapeutic Use
- 18 Apr 2017 New trial record